Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

TriMas (TRS) Q1 Earnings Surpass Estimates, Improve Y/Y

Published 05/01/2019, 09:43 PM
Updated 07/09/2023, 06:31 AM

TriMas Corporation (NASDAQ:TRS) delivered adjusted earnings of 46 cents per share in first-quarter 2019 which surpassed the Zacks Consensus Estimate of 42 cents. The bottom line also improved 12% from 41 cents reported in the prior-year period.

On a reported basis, TriMas reported earnings per share of 42 cents compared with first-quarter 2018’s figure of 53 cents..

The company generated revenues of $221.3 million in the reported quarter, missing the Zacks Consensus Estimate of $225 million. The top-line figure improved 2% year over year on account of organic and acquisition-related sales growth which was partially offset by the unfavorable impact of currency exchange.

TriMas Corporation Price, Consensus and EPS Surprise

Cost and Margins

Cost of sales rose 3% year over year to $161 million in the reported quarter. Gross profit fell 0.9% year over year to $59.8 million. Gross margin contracted 80 bps to 27%.

Selling, general and administrative expenses escalated 35% year over year to $34 million. Adjusted operating profit rose 1.2% to $28.4 million from the prior-year quarter. Adjusted operating margin contracted 10 bps year over year to 12.8% in the quarter.

Segment Performance

Packaging: Net sales inched up around 1% year over year to $89 million as a result of higher sales of health, beauty and home care products related to new product introductions and continued growth in Asia, and incremental sales related to the acquisition of Plastic Srl. Adjusted operating profit dropped 5% year over year to $18.7 million owing to the impact of a less favorable product sales mix and higher costs related to the acquisition of Plastic Srl.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Aerospace: Net sales increased 1.4% year over year to $38.3 million from $37.8 million recorded in the year-earlier quarter, aided by steady demand levels for fasteners. The segment reported adjusted operating profit of $6.2 million, up 35% year over year. This can be attributed to improved production efficiencies and more favorable product sales mix.

Specialty Products: The segment reported revenues of $94 million, an improvement of 3% from $91 million recorded in the prior-year quarter, primarily driven by higher sales levels of all brands due to refocused commercial efforts and higher end-market demand. Adjusted operating profit declined 3% year over year to $10.9 million raw-material cost inflation negated the gains from higher sales levels.

Financial Performance

TriMas reported cash and cash equivalents of $84 million as of Mar 31, 2019, lower than $108 million as of Dec 31, 2018. The company generated $8.1 million of cash from operating activities during the first quarter of 2019 compared with $16.2 million reported in the prior-year quarter. At the end of 2018, net debt was approximately $210 million, up from $185 million as of Dec 31, 2018.

TriMas acquired Taplast S.p.A., a designer and manufacturer of dispensers, closures and containers for the beauty and personal care, household, and food and beverage packaging end markets in Europe and North America. Taplast generated revenues of approximately $32 million in 2018. Taplast will be a wholly-owned division of TriMas’ Rieke business and will be reported in the Packaging segment.

This acquisition, along with the prior buyout of Plastic Srl completed in January 2019, will augment TriMas’ product breadth, geographic presence, and innovation and engineering capabilities.

Guidance

TriMas maintained full-year 2019 organic sales growth guidance at 3-5%. The company anticipates earnings per share to lie between $1.82 and $1.92. The mid-point of the guidance range projects year-over-year growth of 5%. Free cash flow in 2019 is expected to be greater than 100% of net income.

Through 2019, TriMas will continue to focus on the TriMas Business Model, and also strive to pursue growth through innovation, and capitalize on market opportunities.

Share Price Performance

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Over the past year, shares of TriMas have gained around 14.9%, against the industry’s decline of 14.6%.

Zacks Rank & Stocks to Consider

TriMas currently carries a Zacks Rank #3 (Hold).

A few better-ranked stocks in the Industrial Products sector are DMC Global Inc. (NASDAQ:BOOM) , DXP Enterprises, Inc. (NASDAQ:DXPE) and Lawson Products, Inc. (NASDAQ:LAWS) , all sporting a Zacks Rank #1 (Strong Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

DMC Global has an estimated earnings growth rate of 78.7% for the ongoing year. The company’s shares have soared 79% in the past year.

DXP Enterprises has a projected earnings growth rate of 22.7% for the current year. The stock has appreciated 15% in a year’s time.

Lawson Products has an expected earnings growth rate of 24.5% for the current year. The stock has appreciated 49% in a year’s time.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>



DXP Enterprises, Inc. (DXPE): Free Stock Analysis Report

DMC Global Inc. (BOOM): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

TriMas Corporation (TRS): Free Stock Analysis Report

Lawson Products, Inc. (LAWS): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.